UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Colony-Stimulating Factors for Febrile Neutropenia during Cancer Therapy

The New England journal of medicine, 2013-03, Vol.368 (12), p.1131-1139

2013

Volltextzugriff (PDF)

Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients

International journal of antimicrobial agents, 2017-09, Vol.50 (3), p.308-317

2017

Volltextzugriff (PDF)

Generic oncology drugs: are they all safe?

The lancet oncology, 2016-11, Vol.17 (11), p.e493-e501

2016

Volltextzugriff (PDF)

Pharmacists' roles in oncology pharmacy services: Results of a global survey

Journal of oncology pharmacy practice, 2017-04, Vol.23 (3), p.185-194

2017

Volltextzugriff (PDF)

Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre‐ibrutinib era: Incidence and risk factors

Cancer medicine (Malden, MA), 2019-05, Vol.8 (5), p.2233-2240

2019

Volltextzugriff (PDF)

Stability and compatibility of antimicrobial lock solutions

American journal of health-system pharmacy, 2013-12, Vol.70 (24), p.2185-2198

2013

Volltextzugriff (PDF)

Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies

Pharmacotherapy, 2019-12, Vol.39 (12), p.1190-1203

2019

Volltextzugriff (PDF)

Linking Drugs to Obscure Illnesses: Lessons from Pure Red Cell Aplasia, Nephrogenic Systemic Fibrosis, and Reye's Syndrome. A Report From the Southern Network on Adverse Reactions (SONAR)

Journal of general internal medicine : JGIM, 2012-12, Vol.27 (12), p.1697-1703

2012

Volltextzugriff (PDF)

Reply to A.M. Zeidan et al

Journal of clinical oncology, 2017-10, Vol.35 (28), p.3265-3265

2017

Volltextzugriff (PDF)

Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada

The oncologist (Dayton, Ohio), 2019-04, Vol.24 (4), p.537-548

2019

Volltextzugriff (PDF)

Progressive multi‐focal leucoencephalopathy among ibrutinib‐treated persons with chronic lymphocytic leukaemia

British journal of haematology, 2018-01, Vol.180 (2), p.301-304

2018

Volltextzugriff (PDF)

Toxicity and costs of toxicity associated with new cancer drugs: international implications

Journal of clinical oncology, 2014-11, Vol.32 (32), p.3591-3592

2014

Volltextzugriff (PDF)

Assessing pharmacy residents' knowledge of biostatistics and research study design

The Annals of pharmacotherapy, 2012-07, Vol.46 (7-8), p.991-999

2012

Volltextzugriff (PDF)

Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the "ANTICIPATE" Framework

American journal of therapeutics, 2018-11, Vol.25 (6), p.e670-e674

2018

Volltextzugriff (PDF)

Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)

Cancer medicine (Malden, MA), 2017-07, Vol.6 (7), p.1541-1551

2017

Volltextzugriff (PDF)

Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease

Clinical kidney journal, 2012-02, Vol.5 (1), p.82-88

2012

Volltextzugriff (PDF)

Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis

JNCI : Journal of the National Cancer Institute, 2013-08, Vol.105 (15), p.1072-1073

2013

Volltextzugriff (PDF)

Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network

The Journal of community and supportive oncology, 2016-02, Vol.14 (2), p.54-65

2016

Volltextzugriff (PDF)

Linking Drugs to Obscure Illnesses: Lessons from Pure Red Cell Aplasia, Nephrogenic Systemic Fibrosis, and Reye’s Syndrome. A Report From the Southern Network on Adverse Reactions (SONAR)

Journal of general internal medicine : JGIM, 2012-12, Vol.27 (12), p.1697-1703

2012

Volltextzugriff (PDF)

Colony-stimulating factors for febrile neutropenia

The New England journal of medicine, 2013-07, Vol.369 (3), p.286-286

2013

Volltextzugriff (PDF)

Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication

Expert opinion on drug safety, 2011-07, Vol.10 (4), p.521-528

2011

Volltextzugriff (PDF)

Ingestion of hand sanitizer by a hospitalized patient with a history of alcohol abuse

American journal of health-system pharmacy, 2008-12, Vol.65 (23), p.2203-2204

2008

Volltextzugriff (PDF)

Use of Wikis in advanced pharmacy practice experiences

American journal of pharmaceutical education, 2009-12, Vol.73 (8), p.139-139

2009

Volltextzugriff (PDF)

Forewarned Is Forearmed- Comparison of Southern Network on Adverse Reactions (SONAR) Versus an FDA-Mandated Prospective Observational Registry Assessment of Gemtuzumab Ozogamycin-Associated Sinusoidal Obstructive Syndrome

Blood, 2014-12, Vol.124 (21), p.5970-5970

2014

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(41)
Buchkapitel
(1)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Colony-Stimulating Factors for Febrile Neutropenia during Cancer Therapy

Systematic review of antimicrobial lock therapy for prevention of central-line-associated bloodstream infections in adult and pediatric cancer patients

Generic oncology drugs: are they all safe?

Pharmacists' roles in oncology pharmacy services: Results of a global survey

Major hemorrhage in chronic lymphocytic leukemia patients in the US Veterans Health Administration system in the pre‐ibrutinib era: Incidence and risk factors

Stability and compatibility of antimicrobial lock solutions

Hepatitis B Virus Reactivation: Risk Factors and Current Management Strategies

Linking Drugs to Obscure Illnesses: Lessons from Pure Red Cell Aplasia, Nephrogenic Systemic Fibrosis, and Reye's Syndrome. A Report From the Southern Network on Adverse Reactions (SONAR)

Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) project

Reply to A.M. Zeidan et al

Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada

Progressive multi‐focal leucoencephalopathy among ibrutinib‐treated persons with chronic lymphocytic leukaemia

Toxicity and costs of toxicity associated with new cancer drugs: international implications

Assessing pharmacy residents' knowledge of biostatistics and research study design

Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the "ANTICIPATE" Framework

Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)

Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease

Primary prophylaxis with hematopoietic colony stimulating factor: insights from a Canadian cost-effectiveness analysis

Fluoroquinolone-related neuropsychiatric and mitochondrial toxicity: a collaborative investigation by scientists and members of a social network

Linking Drugs to Obscure Illnesses: Lessons from Pure Red Cell Aplasia, Nephrogenic Systemic Fibrosis, and Reye’s Syndrome. A Report From the Southern Network on Adverse Reactions (SONAR)

Colony-stimulating factors for febrile neutropenia

Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedication

Ingestion of hand sanitizer by a hospitalized patient with a history of alcohol abuse

Use of Wikis in advanced pharmacy practice experiences

Forewarned Is Forearmed- Comparison of Southern Network on Adverse Reactions (SONAR) Versus an FDA-Mandated Prospective Observational Registry Assessment of Gemtuzumab Ozogamycin-Associated Sinusoidal Obstructive Syndrome

Suchergebnisse filtern